Malignant Solid Tumour
3 competing products in clinical development for Malignant Solid Tumour.
Pipeline by Phase
Phase 1/23
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tivantinib + FOLFOX | Daiichi Sankyo | Phase 1/2 | Completed | 32 |
| E7449 alone + E7449 plus TMZ + E7449 plus carboplatin and paclitaxel | Eisai | Phase 1/2 | Completed | 32 |
| Eribulin + Cyclophosphamide | Eisai | Phase 1/2 | Completed | 32 |